Podcasts by MRC CTU Podcasts
The Trial Talk podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We delve into trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement is shaping our studies, and discover new ways to run smarter studies.
Further podcasts by MRC Clinical Trials Unit at UCL
Podcast on the topic Wissenschaft
All episodes
World AIDS Day (part 2): Bringing hope through research to young people living with HIV from 2023-12-01T08:32:06
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS...
Listen
World AIDS Day (part 1): Closing the gap between adults and children from 2023-12-01T08:30:06
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS...
Listen
Octopus (part 4): Involvement of people affected by MS with Susan Scott from 2023-11-09T10:00:16
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage pla...
Listen
Octopus (part 3): The patients’ experience with Dawn Lyle and Matthew Justin from 2023-11-02T09:00:14
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage pla...
Listen
Octopus (part 2): Introducing the trial with Jeremy Chataway from 2023-10-26T09:00:12
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage pla...
Listen
Octopus (part 1): The MS landscape with Jeremy Chataway, Dawn Lyle and Matthew Justin from 2023-10-19T07:39:55
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC CTU at UCL. Thanks to its multi-arm multi-stage platform design, Oct...
Listen
Optimising treatments with the new MAMS-ROCI design from 2023-09-21T09:06:52
Innovative platform designs present an opportunity to run faster and more efficient clinical trials. Clinical trials methodology is a research area that looks at how to improve the design, condu...
Listen
STAMPEDE (part 3): Impact and legacy with Max Parmar&Nick James from 2023-08-24T08:03:48
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different tre...
Listen
STAMPEDE (part 2): The role of the patient voice with David Matheson, Max Parmar&Nick James from 2023-08-17T08:09:41
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different tre...
Listen
STAMPEDE (part 1): A new era for prostate cancer research with Max Parmar&Nick James from 2023-08-10T08:04:14
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different tre...
Listen
The REFINE trial: How can we improve the way we give cancer immunotherapy? from 2023-07-18T00:00
Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many p...
Listen
How can clinical trials make the most of healthcare systems data? from 2023-06-26T08:59:55
Running a clinical trial means collecting a lot of data from the trial participants. But some of this data might be collected and stored in healthcare systems, as well as in clinical trial case rep...
Listen
Neonatal infections (part 2): How the NeoSep1 trial will help treat sick newborns from 2023-06-09T08:13:52
Neonatal sepsis is a life-threatening infection that affects up to 3 million babies per year globally. In an effort to identify better treatments, the NeoSep1 clinical trial evaluates new antibio...
Listen
Neonatal infections (part 1): The NeoOBS study and the global challenge of neonatal sepsis from 2023-05-22T08:04:10
214,000 newborn babies die of sepsis caused by infections that are resistant to antibiotics every year. This is a major problem worldwide, but disproportionally affects low- and middle- income coun...
Listen
The STREAM2 trial: How should we treat multi-drug resistant tuberculosis? from 2023-03-24T07:00:48
For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, disc...
Listen
Sharing results of clinical trials with participants (part 1) from 2021-10-19T11:26:02
Clinical trials depend on people volunteering to take part, often at increased risk or inconvenience. Previous research shows that most trial participants want to know what the trial eventually fin...
Listen
Ovarian Cancer Screening - the results of the UKCTOCS trial from 2021-05-13T07:09:45
Around 4000 women die of ovarian cancer in the UK each year. It is often diagnosed at an advanced stage, making treatment difficult. The UK Collaborative Trial of Ovarian Cancer Screening, known as...
Listen
Andrew Nunn talks Medical Statistics, TB, and Algerian Nomads (Part 2) from 2018-10-29T16:05:18
Andrew Nunn joined the MRC’s Tuberculosis&Chest Diseases Unit as a statistician in 1966. During the next 20 years he was directly involved in the design, conduct and analysis of the programme of tr...
Listen
Andrew Nunn talks Medical Statistics, TB, and Algerian Nomads (Part 1) from 2018-10-29T16:05:01
Andrew Nunn joined the MRC’s Tuberculosis&Chest Diseases Unit as a statistician in 1966. During the next 20 years he was directly involved in the design, conduct and analysis of the programme of tr...
Listen
Jayne Tierney talks Systematic Reviews, Impact, and Fish Parasites... from 2018-04-17T15:56:58
Jayne Tierney has been a Research Scientist at the Unit since it was formed in 1999, and prior to that, in the Cancer Trials Office in Cambridge. For more than 20 years, she has been responsible fo...
Listen
ARREST: rifampicin for Staph. aureus bacteraemia (short version) from 2017-12-15T00:00
Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores t...
Listen
ARREST: rifampicin for Staph. aureus bacteraemia (full length) from 2017-12-15T00:00
Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores t...
Listen
Patrick Royston Receives The Stata Journal Editors' Prize 2016 from 2017-09-05T13:13:20
Back in January 2017, Professor Patrick Royston was awarded the Stata Journal Editors’ Prize 2016, for his significant contributions to Stata and the Stata community over the last 25 years, and for...
Listen